{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:12:01Z","timestamp":1790039521732,"version":"4.0.1"},"reference-count":152,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001739","name":"National Institute for Psychobiology in Israel, Hebrew University of Jerusalem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2017.00156","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T23:45:45Z","timestamp":1503445545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":138,"title":["Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health"],"prefix":"10.3389","volume":"8","author":[{"given":"Aviv M.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edythe D.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: the science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YCO.0000000000000071","article-title":"Emerging drugs in Europe","volume":"27","author":"Papaseit","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones \u2013 an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Sci Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/YCO.0000000000000066","article-title":"Mephedrone and other cathinones","volume":"27","author":"Zawilska","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.irn.2015.02.009","article-title":"\u201cLegal highs\u201d \u2013 an emerging epidemic of novel psychoactive substances","volume":"120","author":"Zawilska","year":"2015","journal-title":"Int Rev Neurobiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/13816128113199990622","article-title":"New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature","volume":"20","author":"Cottencin","year":"2014","journal-title":"Curr Pharm Des"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin Toxicol"},{"key":"B9","volume-title":"World Drug Report","year":"2015"},{"key":"B10","volume-title":"New Psychoactive Substances in Europe (2015). An Update from the EU Early Warning System","year":"2015"},{"key":"B11","first-page":"618","article-title":"Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use \u2013 United States, January-May 2015","volume":"64","author":"Law","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/2210676611303020003","article-title":"Novel drugs of abuse: a snapshot of an evolving marketplace","volume":"3","author":"Vandrey","year":"2013","journal-title":"Adolesc Psychiatry"},{"key":"B13","volume-title":"World Drug Report","year":"2016"},{"key":"B14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.neuropharm.2015.08.041","article-title":"Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a spice cannabinoid","volume":"99","author":"De Luca","year":"2015","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnins.2016.00153","article-title":"Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants","volume":"10","author":"Miliano","year":"2016","journal-title":"Front Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/npp.2015.260","article-title":"Abuse of new psychoactive substances (NPS): threats and solutions","volume":"41","author":"Baumann","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/S0196-0644(05)80419-6","article-title":"Methcathinone: a Russian designer amphetamine infiltrates the rural midwest","volume":"22","author":"Emerson","year":"1993","journal-title":"Ann Emerg Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1570159X13666141210225009","article-title":"Cathinone neurotoxicity (the \u201c3Ms\u201d)","volume":"13","author":"Karch","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"B20","volume-title":"Thematic Paper \u2013 Understanding the \u2018Spice\u2019 Phenomenon","year":"2009"},{"key":"B21","unstructured":"Synthetic Marijuana\n            MacherR\n            BurkeTW\n            OwenSS\n          FBI Law Enforcement Bulletin2012"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MAJ.0000000000000466","article-title":"Synthetic cannabinoids","volume":"350","author":"Mills","year":"2015","journal-title":"Am J Med Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B24","volume-title":"Cannabimimetic Indole Derivates","author":"Makriyannis","year":"2007"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/ntr\/nts257","article-title":"Gender differences in patterns and correlates of khat and tobacco use","volume":"15","author":"Nakajima","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/09595239600185691","article-title":"Chewing as a social act: cultural displacement and khat consumption in the East African communities of Melbourne","volume":"15","author":"Stevenson","year":"1996","journal-title":"Drug Alcohol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/02791072.2014.962717","article-title":"Investigation of \u201cbath salts\u201d use patterns within an online sample of users in the United States","volume":"46","author":"Johnson","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/dta.1625","article-title":"Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones","volume":"6","author":"P\u00e9terfi","year":"2014","journal-title":"Drug Test Anal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/qjmed\/hcq134","article-title":"Mephedrone use and associated adverse effects in school and college\/university students before the UK legislation change","volume":"103","author":"Dargan","year":"2010","journal-title":"QJM"},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drugpo.2015.03.005","article-title":"Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia and the perceived problems experienced by users","volume":"27","author":"Sande","year":"2016","journal-title":"Int J Drug Policy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","article-title":"Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project","volume":"243","author":"Helander","year":"2014","journal-title":"Forensic Sci Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","article-title":"\u201cSpice\u201d and \u201cK2\u201d herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans","volume":"21","author":"Gunderson","year":"2012","journal-title":"Am J Addict"},{"key":"B33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2190\/DE.43.4.d","article-title":"Reasons for synthetic THC use among college students","volume":"43","author":"Vidourek","year":"2013","journal-title":"J Drug Educ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/01.pra.0000413274.09305.9c","article-title":"Synthetic cannabinoid use: recognition and management","volume":"18","author":"Castellanos","year":"2012","journal-title":"J Psychiatr Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1747-597X-6-16","article-title":"College students and use of K2: an emerging drug of abuse in young persons","volume":"6","author":"Hu","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/a0038014","article-title":"Investigating correlates of synthetic marijuana and Salvia use in light and intermittent smokers and college students in a predominantly Hispanic sample","volume":"22","author":"Gutierrez","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/08897077.2014.959151","article-title":"Synthetic cannabinoids: use and predictors in a community sample of young adults","volume":"36","author":"Caviness","year":"2015","journal-title":"Subst Abus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00952990.2015.1043438","article-title":"K2 and spice use among a cohort of college students in southeast region of the USA","volume":"1","author":"Egan","year":"2015","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.01.044","article-title":"Synthetic cannabinoid use in a nationally representative sample of US high school seniors","volume":"149","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.drugalcdep.2014.07.009","article-title":"Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates","volume":"143","author":"Bonar","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B43","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/0269881115574493","article-title":"Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample","volume":"29","author":"Winstock","year":"2015","journal-title":"J Psychopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1465-3362.2012.00519.x","article-title":"Patterns of synthetic cannabinoid use in Australia","volume":"32","author":"Barratt","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/dar.12312","article-title":"Patterns and correlates of new psychoactive substance use in a sample of Australian high school students","volume":"35","author":"Champion","year":"2016","journal-title":"Drug Alcohol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpeds.2012.12.056","article-title":"Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States","volume":"163","author":"Wood","year":"2013","journal-title":"J Pediatr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \u201cbath salts\u201d: not so soothing","volume":"698","author":"Baumann","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/dar.12058","article-title":"Novel psychoactive drug use among younger adults involved in US nightlife scenes","volume":"32","author":"Kelly","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","article-title":"Effects of synthetic cathinones contained in \u201cbath salts\u201d on motor behavior and a functional observational battery in mice","volume":"33","author":"Marusich","year":"2012","journal-title":"Neurotoxicology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"\u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"yu014","DOI":"10.1093\/ijnp\/pyu014","article-title":"Effects of \u03b1-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation \u201cbath salts,\u201d on intracranial self-stimulation thresholds in rats","volume":"18","author":"Watterson","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone, and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2014","journal-title":"Psychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/bph.12951","article-title":"Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats","volume":"172","author":"Gregg","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.S9-002","article-title":"The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in \u201cbath salts\u201d","author":"Watterson","year":"2012","journal-title":"J Addict Res Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4062\/biomolther.2016.241","article-title":"The abuse potential of \u03b1-piperidinopropiophenone (PIPP) and \u03b1-piperidinopentiothiophenone (PIVT), two new synthetic cathinones with piperidine ring substituent","volume":"25","author":"Botanas","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pbb.2016.12.017","article-title":"The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity","volume":"153","author":"Botanas","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"B59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbr.2016.10.016","article-title":"A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice","volume":"317","author":"Botanas","year":"2017","journal-title":"Behav Brain Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00213-017-4526-8","article-title":"Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents","volume":"234","author":"Cheong","year":"2017","journal-title":"Psychopharmacology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12472","article-title":"The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation","author":"Oh","year":"2016","journal-title":"Addict Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00213-016-4492-6","article-title":"Self-administration and behavioral economics of second-generation synthetic cathinones in male rats","volume":"234","author":"Huskinson","year":"2017","journal-title":"Psychopharmacology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bcpt.12253","article-title":"Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice","volume":"115","author":"Karlsson","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00213-014-3755-3","article-title":"Discriminative and locomotor effects of five synthetic cathinones in rats and mice","volume":"232","author":"Gatch","year":"2015","journal-title":"Psychopharmacology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.04.014","article-title":"Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator","volume":"108","author":"Gregg","year":"2016","journal-title":"Neuropharmacology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"yv120","DOI":"10.1093\/ijnp\/pyv120","article-title":"The effects of 4-methylethcathinone on conditioned place preference, locomotor sensitization, and anxiety-like behavior: a comparison with methamphetamine","volume":"19","author":"Xu","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pbb.2015.07.013","article-title":"Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences","volume":"137","author":"King","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"B68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.drugalcdep.2015.02.002","article-title":"Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats","volume":"149","author":"Naylor","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/jpet.115.223586","article-title":"Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives","volume":"354","author":"Gatch","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.genhosppsych.2012.06.005","article-title":"Excited delirium following use of synthetic cathinones (bath salts)","volume":"34","author":"Penders","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3371\/CSRP.JORO.061314","article-title":"Bath salts abuse leading to new onset psychosis and potential for violence","volume":"20","author":"John","year":"2014","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"B72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J Anal Toxicol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00414-015-1212-4","article-title":"Death following ingestion of methylone","volume":"130","author":"Barrios","year":"2016","journal-title":"Int J Legal Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00952990.2012.677890","article-title":"Synthetic cathinone exposures reported to Texas poison centers","volume":"38","author":"Forrester","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/SAR.S37257","article-title":"Emerging drugs of abuse: current perspectives on substituted cathinones","volume":"5","author":"Paillet-Loilier","year":"2014","journal-title":"Subst Abuse Rehabil"},{"key":"B76","doi-asserted-by":"publisher","first-page":"288","DOI":"10.12659\/AJCR.889381","article-title":"\u201cBath salts\u201d induced severe reversible cardiomyopathy","volume":"14","author":"Sivagnanam","year":"2013","journal-title":"Am J Case Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2014.03.003","article-title":"Seizures associated with synthetic cathinone exposures in the pediatric population","volume":"51","author":"Tekulve","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.forsciint.2014.10.027","article-title":"Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone","volume":"245","author":"Pichini","year":"2014","journal-title":"Forensic Sci Int"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1111\/bph.13547","article-title":"Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters","volume":"173","author":"Mayer","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7854_2016_53","article-title":"Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs","volume":"32","author":"Baumann","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/adb.12201","article-title":"Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects","volume":"21","author":"Anizan","year":"2016","journal-title":"Addict Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u0394 (9)-THC: mechanism underlying greater toxicity?","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of \u2018spice\u2019 herbal blends, is a potent and efficacious cannabinoid CB receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2011.01.066","article-title":"CP47,497-C8 and JWH073, commonly found in \u2018spice\u2019 herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists","volume":"659","author":"Atwood","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2174\/0929867054020864","article-title":"Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes","volume":"12","author":"Huffman","year":"2005","journal-title":"Curr Med Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bmc.2004.09.050","article-title":"Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists","volume":"13","author":"Huffman","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.forsciint.2009.06.008","article-title":"Spice: a never ending story?","volume":"191","author":"Lindigkeit","year":"2009","journal-title":"Forensic Sci Int"},{"key":"B89","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/156802608783498014","article-title":"Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"d5395","DOI":"10.1136\/bmj.d5395","article-title":"New Zealand bans synthetic cannabinoids","volume":"343","author":"Brown","year":"2011","journal-title":"BMJ"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/jms.1811","article-title":"Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds","volume":"45","author":"Dresen","year":"2010","journal-title":"J Mass Spectrom"},{"key":"B92","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00216-011-4743-7","article-title":"Comparison of \u201cherbal highs\u201d composition","volume":"400","author":"Zuba","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.drugalcdep.2012.05.034","article-title":"Inhalation exposure to smoke from synthetic \u201cmarijuana\u201d produces potent cannabimimetic effects in mice","volume":"126","author":"Wiebelhaus","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","article-title":"In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid \u03949-THC in mice: inhalation versus intraperitoneal injection","volume":"124","author":"Marshell","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"B95","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/FBP.0000000000000093","article-title":"\u03949-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2\/Spice","volume":"25","author":"Gatch","year":"2014","journal-title":"Behav Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/FBP.0000000000000150","article-title":"\u03949-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market","volume":"26","author":"Gatch","year":"2015","journal-title":"Behav Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.115.225326","article-title":"AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing \u03949-tetrahydrocannabinol-like effects in mice","volume":"354","author":"Wiley","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"B98","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuroscience.2015.05.021","article-title":"JWH-018 impairs sensorimotor functions in mice","volume":"300","author":"Ossato","year":"2015","journal-title":"Neuroscience"},{"key":"B100","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4062\/biomolther.2014.039","article-title":"Dependence potential of the synthetic cannabinoids JWH-073, JWH-081, and JWH-210: in vivo and in vitro approaches","volume":"22","author":"Cha","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4062\/biomolther.2015.120","article-title":"Assessment of the abuse liability of synthetic cannabinoid agonists JWH-030, JWH-175, and JWH-176","volume":"23","author":"Tampus","year":"2015","journal-title":"Biomol Ther (Seoul)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00213-016-4237-6","article-title":"\u0394(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats","volume":"233","author":"Gatch","year":"2016","journal-title":"Psychopharmacology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016","article-title":"Comparison of the discriminative stimulus and response rate effects of \u03949-tetrahydrocannabinol and synthetic cannabinoids in female and male rats","volume":"172","author":"Wiley","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"B104","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejphar.2014.06.023","article-title":"JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects","volume":"740","author":"Rodriguez","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1124\/jpet.117.240572","article-title":"Apparent affinity estimates and reversal of the effects of synthetic cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by rimonabant in rhesus monkeys","volume":"362","author":"Hruba","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"B106","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40429-014-0018-7","article-title":"Impact of cannabis use on the development of psychotic disorders","volume":"1","author":"Wilkinson","year":"2014","journal-title":"Curr Addict Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpsyt.2014.00054","article-title":"Gone to pot \u2013 a review of the association between cannabis and psychosis","volume":"5","author":"Radhakrishnan","year":"2014","journal-title":"Front Psychiatry"},{"key":"B108","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J Psychopharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.biopsych.2016.02.001","article-title":"Synthetic cannabinoids\u2013further evidence supporting the relationship between cannabinoids and psychosis","volume":"79","author":"Fattore","year":"2016","journal-title":"Biol Psych"},{"key":"B111","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/15504263.2014.929364","article-title":"Use of synthetic cannabinoids in patients with psychotic disorders: case series","volume":"10","author":"Celofiga","year":"2014","journal-title":"J Dual Diagn"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.3928\/01477447-20140401-62","article-title":"Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations","volume":"37","author":"Meijer","year":"2014","journal-title":"Orthopedics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"310930","DOI":"10.1155\/2015\/310930","article-title":"Synthetic cannabis-induced mania","volume":"2015","author":"Ustundag","year":"2015","journal-title":"Case Rep Psychiatry"},{"key":"B114","first-page":"430","article-title":"Suicidal ideation and self-harm following K2 use","volume":"105","author":"Thomas","year":"2012","journal-title":"J Okla State Med Assoc"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.009","article-title":"Cannabis and adolescent brain development","volume":"148","author":"Lubman","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000430437","article-title":"Thalamic and cerebellar gray matter volume reduction in synthetic cannabinoids users","volume":"21","author":"Nurmedov","year":"2015","journal-title":"Eur Addict Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.euroneuro.2013.01.009","article-title":"Effects of acute detoxification of the herbal blend \u2018spice gold\u2019 on dopamine D2\/3 receptor availability: a [18F]fallypride PET study","volume":"23","author":"Rominger","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jat\/bkt065","article-title":"Blood synthetic cannabinoid concentrations in cases of suspected impaired driving","volume":"37","author":"Yeakel","year":"2013","journal-title":"J Anal Toxicol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.forsciint.2014.06.010","article-title":"Retrospective analysis of synthetic cannabinoids in serum samples\u2014epidemiology and consumption patterns","volume":"242","author":"Jaenicke","year":"2014","journal-title":"Forensic Sci Int"},{"key":"B120","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00414-013-0864-1","article-title":"Driving under the influence of synthetic cannabinoids (\u201cspice\u201d): a case series","volume":"128","author":"Musshoff","year":"2014","journal-title":"Int J Legal Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15389588.2015.1018990","article-title":"The influence of synthetic cannabinoid UR-144 on human psychomotor performance \u2013 a case report demonstrating road traffic risks","volume":"20","author":"Adamowicz","year":"2015","journal-title":"Traffic Inj Prev"},{"key":"B122","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.aap.2013.09.009","article-title":"Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period","volume":"62","author":"Tuv","year":"2014","journal-title":"Accid Anal Prev"},{"key":"B123","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.forsciint.2014.11.012","article-title":"Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids","volume":"246","author":"Karinen","year":"2015","journal-title":"Forensic Sci Int"},{"key":"B124","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMp1505328","article-title":"Synthetic cannabinoid-related illnesses and deaths","volume":"373","author":"Trecki","year":"2015","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0034-1399307","article-title":"Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard","volume":"83","author":"Bonnet","year":"2015","journal-title":"Fortschr Neurol Psychiatr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.forsciint.2015.04.021","article-title":"Case reports of synthetic cannabinoid XLR-11 associated fatalities","volume":"252","author":"Shanks","year":"2015","journal-title":"Forensic Sci Int"},{"key":"B127","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jemermed.2015.06.053","article-title":"Synthetic cannabinoid abuse in adolescents: a case series","volume":"49","author":"Besli","year":"2015","journal-title":"Emerg Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.030","article-title":"Synthetic cannabis and acute ischemic stroke","volume":"23","author":"Bernson-Leung","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s13054-014-0553-6","article-title":"A \u2018spicy\u2019 encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure","volume":"18","author":"Louh","year":"2014","journal-title":"Crit Care"},{"key":"B130","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/15563650.2014.925562","article-title":"\u2018Crazy monkey\u2019 poisons man and dog: human and canine seizures due to PB-22, a novel synthetic cannabinoid","volume":"52","author":"Gugelmann","year":"2014","journal-title":"Clin Toxicol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3109\/15563650.2014.958614","article-title":"A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid","volume":"52","author":"Takematsu","year":"2014","journal-title":"Clin Toxicol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5152\/tpa.2015.2609","article-title":"Cardiovascular side effects related with use of synthetic cannabinoids \u201cbonsai\u201d two case reports","volume":"50","author":"Atik","year":"2015","journal-title":"Turk Pediatri Ars"},{"key":"B133","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5863\/1551-6776-17.2.177","article-title":"Acute intoxication caused by a synthetic cannabinoid in two adolescents","volume":"17","author":"Heath","year":"2012","journal-title":"J Pediatr Pharmacol Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13181-014-0424-1","article-title":"K2-not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report","volume":"11","author":"McKeever","year":"2015","journal-title":"J Med Toxicol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"120607","DOI":"10.1155\/2014\/120607","article-title":"A unique case of cardiac arrest following K2 abuse","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"Case Rep Cardiol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1016\/j.hlc.2015.04.176","article-title":"Teenage cardiac arrest following abuse of synthetic cannabis","volume":"24","author":"Davis","year":"2015","journal-title":"Heart Lung Circ"},{"key":"B137","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14797\/mdcj-11-3-189","article-title":"A new differential diagnosis: synthetic cannabinoids-associated acute renal failure","volume":"11","author":"Gudsoorkar","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"B138","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/cap.2011.0122","article-title":"Synthetic cannabis and respiratory depression","volume":"22","author":"Jinwala","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13181-013-0288-9","article-title":"High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use","volume":"9","author":"Alhadi","year":"2013","journal-title":"J Med Toxicol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2214\/AJR.14.13138","article-title":"Pulmonary effects of synthetic marijuana: chest radiography and CT findings","volume":"204","author":"Berkowitz","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jemermed.2012.11.034","article-title":"A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids","volume":"45","author":"Hopkins","year":"2013","journal-title":"J Emerg Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"167098","DOI":"10.1155\/2014\/167098","article-title":"A gut gone to pot: a case of cannabinoid hyperemesis syndrome due to K2, a synthetic cannabinoid","volume":"2014","author":"Ukaigwe","year":"2014","journal-title":"Case Rep Emerg Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ADM.0b013e31828e1881","article-title":"The synthetic cannabinoid withdrawal syndrome","volume":"7","author":"Nacca","year":"2013","journal-title":"J Addict Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dar.12225","article-title":"Synthetic cannabinoid withdrawal: a new demand on detoxification services","volume":"34","author":"Macfarlane","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"B145","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugpo.2009.02.002","article-title":"They\u2019re legal so they\u2019re safe, right? What did the legal status of BZP party pills mean to young people in New Zealand","volume":"21","author":"Sheridan","year":"2010","journal-title":"Int J Drug Policy"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/add.12610","article-title":"Regulatory approaches to new psychoactive substances (NPS) in the European Union","volume":"108","author":"Hughes","year":"2014","journal-title":"Addiction"},{"key":"B147","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1021\/ac4024704","article-title":"Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology","volume":"85","author":"Patton","year":"2013","journal-title":"Anal Chem"},{"key":"B148","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1021\/acs.analchem.6b02600","article-title":"Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay","volume":"88","author":"Cannaert","year":"2016","journal-title":"Anal Chem"},{"key":"B149","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in schedule I. Final order","volume":"76","year":"2011","journal-title":"Fed Regist"},{"key":"B150","volume-title":"Legal Approaches to Controlling New Psychoactive Substances","year":"2015"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2169-0170.1000140","article-title":"The recent legal approach to new psychoactive substances regulation in Israel: does it work?","volume":"140","author":"Rosca","year":"2015","journal-title":"J Civil Legal Sci"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/add.12484","article-title":"A critical first assessment of the new pre-market approval regime for the new psycho-active substances (NPS) in New Zealand","volume":"109","author":"Wilkins","year":"2014","journal-title":"Addiction"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T23:45:48Z","timestamp":1503445548000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":152,"alternative-id":["10.3389\/fpsyt.2017.00156"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2017.00156","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]},"article-number":"156"}}